Discovery and optimization of a TRAIL R2 agonist for cancer therapy.
Angell YM, Bhandari A, De Francisco MN, Frederick BT, Green JM, Leu K, Leuther K, Sana R, Schatz PJ, Whitehorn EA, Wright K, Holmes CP.
Angell YM, et al.
Adv Exp Med Biol. 2009;611:101-3. doi: 10.1007/978-0-387-73657-0_45.
Adv Exp Med Biol. 2009.
PMID: 19400112
No abstract available.